SOLV Stock Overview
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Solventum Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$65.01 |
| 52 Week High | US$96.05 |
| 52 Week Low | US$60.72 |
| Beta | 0 |
| 1 Month Change | -6.53% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -18.74% |
Recent News & Updates
Shareholder Returns
| SOLV | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 2.4% | 2.0% | 2.2% |
| 1Y | n/a | -1.4% | 22.8% |
Return vs Industry: Insufficient data to determine how SOLV performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how SOLV performed against the US Market.
Price Volatility
| SOLV volatility | |
|---|---|
| SOLV Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SOLV has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SOLV's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2023 | 20,000 | Bryan Hanson | www.solventum.com |
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.
Solventum Corporation Fundamentals Summary
| SOLV fundamental statistics | |
|---|---|
| Market cap | US$11.38b |
| Earnings (TTM) | US$1.35b |
| Revenue (TTM) | US$8.20b |
8.3x
P/E Ratio1.4x
P/S RatioIs SOLV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SOLV income statement (TTM) | |
|---|---|
| Revenue | US$8.20b |
| Cost of Revenue | US$3.50b |
| Gross Profit | US$4.69b |
| Other Expenses | US$3.35b |
| Earnings | US$1.35b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | 7.79 |
| Gross Margin | 57.25% |
| Net Profit Margin | 16.42% |
| Debt/Equity Ratio | 0% |
How did SOLV perform over the long term?
See historical performance and comparison